Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Effect of Neflamapimod on Brain Inflammation in Alzheimer's Disease Patients (VIP)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03435861
Recruitment Status : Recruiting
First Posted : February 16, 2018
Last Update Posted : November 21, 2018
Sponsor:
Collaborator:
Fondation Plan Alzheimer
Information provided by (Responsible Party):
University Hospital, Toulouse

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : January 30, 2020
Estimated Study Completion Date : January 30, 2021